lobbying_activities: 1837043
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1837043 | d95d6211-f09f-4a75-9fb2-534c6af4efe9 | Q2 | HOLLAND & KNIGHT LLP | 18466 | UNITED MITOCHONDRIAL DISEASE FOUNDATION | 2016 | second_quarter | HCR | Promote FY17 federal funding for mitochondrial disease research, including through Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), Defense Appropriations Act (Title V - Health); Mitochondrial Replacement Therapy. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2016-07-01T14:18:14.993000-04:00 |